Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000083.xml
Synlett 2013; 24(20): 2701-2704
DOI: 10.1055/s-0033-1339924
DOI: 10.1055/s-0033-1339924
letter
Liquid-Phase Split-Type Combinatorial Synthesis of Tripeptide Derivatives Encoded by Fluorous Fmoc Reagents
Further Information
Publication History
Received: 31 July 2013
Accepted after revision: 10 September 2013
Publication Date:
05 November 2013 (online)
Abstract
A liquid-phase mixture synthesis of 18 tripeptides, some of which are analogues of ACE inhibitors, was effectively conducted by using fluorous Fmoc reagents as encoding tags.
Key words
combinatorial chemistry - liquid-phase synthesis - mixture synthesis - fluorous tag - peptidesSupporting Information
- for this article is available online at http://www.thieme-connect.com/ejournals/toc/synlett.
- Supporting Information
-
References and Notes
- 1a Luo Z, Zhang Q, Oderaotoshi Y, Curran DP. Science 2001; 291: 1766
- 1b Manku S, Curran DP. J. Org. Chem. 2005; 70: 4470
- 1c Kojima M, Nakamura Y, Ito S, Takeuchi S. Tetrahedron Lett. 2009; 50: 6143
- 1d Reena B, Curran DP. J. Am. Chem. Soc. 2011; 133: 20435
- 1e Yeh EA.-H, Kumli E, Damodaran K, Curran DP. J. Am. Chem. Soc. 2013; 135: 1577
- 2 Matsugi M, Yamanaka K, Inomata I, Takekoshi N, Hasegawa M, Curran DP. QSAR Comb. Sci. 2006; 25: 713
- 3 Sugiyama Y, Ishihara K, Masuda Y, Kobayashi Y, Hamamoto H, Matsugi M. Tetrahedron Lett. 2013; 54: 2060
- 4a Fustero S, Sancho AG, Chiva G, Sanz-Cervera JF, del Pozo C, Aceña JL. J. Org. Chem. 2006; 71: 3299
- 4b Manzoni L, Castelli R. Org. Lett. 2006; 8: 955
- 4c de Visser PC, van Helden M, Filippov DV, van der Marel GA, Drijfhout JW, van Boom JH, Noort D, Overkleeft HS. Tetrahedron Lett. 2003; 44: 9013
- 5a Miyoshi S, Ishikawa H, Kaneko T, Fukui F, Tanaka H, Maruyama S. Agric. Biol. Chem. 1991; 55: 1313
- 5b Suetsuna K. Kiso to Rinsho 1991; 25: 2245
- 5c Matsui T, Yukiyoshi A, Doi S, Sugimoto H, Yamada H, Matsumoto K. J. Nutr. Biochem. 2002; 13: 80
- 6 Analytical Data for f14-Fmoc-Ala-OH: Pale-yellow solid; mp 95.7–96.5 °C. 1H NMR (270 MHz, CDCl3): δ = 1.49 (d, J = 7.0 Hz, 3 H), 2.31–2.51 (m, 4 H), 2.96–3.02 (m, 4 H), 4.16–4.21 (m, 1 H), 4.39–4.48 (m, 3 H), 5.28 (d, J = 7.0 Hz, 1 H), 7.25 (d, J = 7.3 Hz, 2 H), 7.42 (s, 2 H), 7.68 (d, J = 8.1 Hz, 2 H). 19F NMR (466 MHz, CDCl3): δ = –80.4 (6F), –115.4 (4F), –127.6 (4F); HRMS [FAB+]: m/z calcd for C28H23NO4F14: 704.1482; found: 704.1456.
- 7 Analytical Data for f18-Fmoc-Phe-OH: White solid; mp 122.2–123.1 °C. 1H NMR (270 MHz, CDCl3): δ = 2.33–2.50 (m, 4 H), 2.94–3.00 (m, 4 H), 3.09–3.25 (m, 2 H), 4.13–4.17 (m, 1 H), 4.33–4.47 (m, 2 H), 4.66–4.73 (m, 1 H), 5.21 (d, J = 7.8 Hz, 1 H), 7.12 (d, J = 6.5 Hz, 2 H), 7.23–7.26 (m, 5 H), 7.39 (d, J = 3.8 Hz, 2 H), 7.67 (d, J = 8.6 Hz, 2 H). 19F NMR (466 MHz, CDCl3): δ = –80.8 (6F), –114.7 (4F), –124.2 (4F), –125.9 (4F). HRMS [FAB+]: m/z calcd for C36H27NO4F18: 880.1731; found: 880.1685.
- 8 Analytical Data for f26-Fmoc-Leu-OH: White solid; mp 134.5–135.4 °C. 1H NMR (270 MHz, CDCl3): δ = 0.97 (d, J = 5.4 Hz, 6 H), 1.59–1.76 (m, 3 H), 2.32–2.45 (m, 4 H), 2.96–3.02 (m, 4 H), 4.17–4.22 (m, 1 H), 4.39–4.44 (m, 3 H), 5.11 (d, J = 8.3 Hz, 1 H), 7.24 (d, J = 7.3 Hz, 2 H), 7.43 (s, 2 H), 7.67 (d, J = 8.1 Hz, 2 H). 19F NMR (466 MHz, CDCl3): δ = –80.6 (6F), –114.4 (4F), –121.7 (4F), –122.7 (4F), –123.3 (4F), –125.9 (4F). HRMS [FAB+]: m/z calcd for C37H29NO4F26: 1046.1760; found: 1046.1747.
- 9a Konig W, Geiger R. Chem. Ber. 1970; 103: 788
- 9b Konig W, Geiger R. Chem. Ber. 1970; 103: 2024
- 9c Knorrl R, Trzeciak A, Bannwarth W, Gillessen D. Tetrahedron Lett. 1989; 30: 1927
- 10 Mixture Synthesis for Three-Component Mixture of f14-Fmoc-Ala-Ala-OBn, f18-Fmoc-Phe-Ala-OBn, and f26-Fmoc-Leu-Ala-OBn; Typical Procedure: f14-Fmoc-Ala-OH (560.0 mg, 0.79 mmol), f18-Fmoc-Phe-OH (714.4 mg, 0.79 mmol), and f26-Fmoc-Leu-OH (832.0 mg, 0.79 mmol) were mixed and dissolved in DMF (20 mL). To the solution were added HOBt·H2O (438.8 mg, 2.86 mmol) and HBTU (1086 mg, 2.86 mmol), separately. After stirring for 5 min, Ala-OBn (1.01 g, 2.86 mmol) and DIPEA (974 μL, 5.72 mmol) were added to the above reaction mixture separately. The reaction mixture was stirred for 24 h at room temperature. After the addition of aq 1.0 M HCl and then dilution with ethyl acetate, the organic layer was washed with H2O, sat. aq NaHCO3 and brine, dried over Na2SO4 and concentrated. The crude residue was purified by silica gel chromatography (CHCl3–MeOH, 20:1) to give the title compound (2.4 g, 95% based on the average molecular weight of the mixture).
- 11 Wuts PG. M, Greene TW. Green’s Protective Groups in Organic Synthesis . Wuts PG. M, Greene TW. Wiley-Interscience; New Jersey: 2007. 3rd ed., 415
- 12 Analytical and preparative f-HPLC were conducted by using FluoroFlash® columns purchased from Fluorous Technologies Inc. The corporation is no longer trading; however, fluorous column (Wakopak® Fluofix-II 120E) with almost the same separation ability is available from Wako Pure Chemical Industries, Ltd.
- 13 The f-HPLC separation could also be applied to a tripeptide that was derived from hydrophilic amino acids such as glycine. The f14-Fmoc-Gly-Gly-Gly-OMe, f18-Fmoc-Gly-Gly-Gly-OMe and f26-Fmoc-Gly-Gly-Gly-OMe appeared at 2.4, 3.0, and 6.4 min, respectively, in the analytical f-HPLC trace under the same conditions.
- 14 Analytical Data for f14-Fmoc-Ala-Ala-Ala-OBn: White solid; mp 153.8–154.6 °C. 1H NMR (270 MHz, CDCl3): δ = 1.36–1.42 (m, 9 H), 2.31–2.44 (m, 4 H), 2.96–3.02 (m, 4 H), 4.16–4.19 (m, 1 H), 4.22–4.28 (m, 1 H), 4.39–4.50 (m, 3 H), 4.56–4.61 (m, 1 H), 5.13 (d, J = 11.9 Hz, 1 H), 5.19 (d, J = 12.7 Hz, 1 H), 5.44 (d, J = 7.3 Hz, 1 H), 6.55–6.62 (m, 2 H), 7.24 (d, J = 9.9 Hz, 2 H), 7.31–7.36 (m, 5 H), 7.42 (s, 2 H), 7.68 (d, J = 8.1 Hz, 2 H). 19F NMR (466 MHz, CDCl3): δ = –80.3 (6F), –115.4 (4F), –127.6 (4F). HRMS [FAB+]: m/z calcd for C41H40N3O6F14: 936.2694; found: 936.2704.
- 15 Analytical Data for f18-Fmoc-Phe-Ala-Ala-OBn: White solid; mp 171.5–172.4 °C. 1H NMR (270 MHz, CDCl3): δ = 1.30 (d, J = 6.8 Hz, 3 H), 1.40 (d, J = 7.3 Hz, 3 H), 2.34–2.44 (m, 4 H), 2.95–3.02 (m, 4 H), 3.07–3.11 (m, 2 H), 4.10–4.15 (m, 1 H), 4.30–4.46 (m, 4 H), 4.52–4.58 (m, 1 H), 5.13 (d, J = 11.9 Hz, 1 H), 5.19 (d, J = 12.7 Hz, 1 H), 5.35 (d, J = 6.8 Hz, 1 H), 6.38 (d, J = 5.9 Hz, 1 H), 6.45 (d, J = 7.0 Hz, 1 H), 7.13–7.16 (m, 2 H), 7.23–7.40 (m, 12 H), 7.68 (d, J = 7.8 Hz, 2 H). 19F NMR (466 MHz, CDCl3): δ = –80.6 (6F), –114.5 (4F), –124.1 (4F), –125.8 (4F); HRMS [FAB+]: m/z calcd for C52H45N3O5F18: 1112.2943; found: 1112.2969.
- 16 Analytical Data for f26-Fmoc-Leu-Ala-Ala-OBn: White solid; mp 179.9–181.0 °C. 1H NMR (270 MHz, CDCl3): δ = 0.94 (d, J = 5.4 Hz, 6 H), 1.36–1.42 (m, 6 H), 1.50–1.70 (m, 3 H), 2.35–2.48 (m, 4 H), 2.96–3.02 (m, 4 H), 4.15–4.20 (m, 2 H), 4.36–4.59 (m, 3 H), 4.45–4.59 (m, 1 H), 5.16–5.22 (m, 3 H), 6.48 (d, J = 6.5 Hz, 2 H), 7.32–7.43 (m, 9 H), 7.68 (d, J = 7.2 Hz, 2 H). 19F NMR (466 MHz, CDCl3): δ = –80.6 (6F), –114.4 (4F), –121.6 (4F), –122.6 (4F), –123.2 (4F), –125.9 (4F). HRMS [FAB+]: m/z calcd for C52H46N3O6F26: 1278.2971; found: 1278.3009.
- 17 Analytical data for these tripeptides are provided in the Supporting Information
For examples, see:
For examples of peptides synthesis using fluorous tags, see: